Florida Appeals Court Rejects Rules Protecting Physician Dispensing in Workers’ Compensation Cases

Why It Matters

Insurers gain greater discretion over prescription coverage, directly affecting reimbursement flows and practice revenue models in the workers’ compensation market.

Key Takeaways

• DCA struck down DFS rules expanding “absolute choice” to physicians.
• Insurers can now deny reimbursement for practitioner‑dispensed meds.
• Practices may need pharmacy licenses to retain higher reimbursement rates.
• Legislative change required to restore dispensing protections.
• Denial scrutiny likely to increase for workers’ comp claims.

Pulse Analysis

Florida’s workers’ compensation framework has long balanced insurer control with the statutory "free, full, and absolute choice" for patients to select their pharmacy. In 2020, the Department of Financial Services attempted to broaden that choice to include physicians dispensing medications, issuing a bulletin and later formal rules. The First DCA’s recent decision clarified that the statutory language applies solely to licensed pharmacists and pharmacies, rendering the DFS rules an overreach. This judicial interpretation reasserts the legislature’s exclusive role in redefining the scope of "absolute choice".

For medical practices that dispense drugs to injured workers, the ruling introduces operational and financial challenges. Insurers can now deny authorization or reimbursement for practitioner‑dispensed prescriptions, pushing providers toward the traditional pharmacy model. While dispensing remains legal, the higher reimbursement rate—112.5% of average wholesale price plus an $8.00 fee—applies only to dispensing practitioners. Converting to a licensed pharmacy would shift reimbursement to the standard average wholesale price plus $4.18, potentially reducing margins. Practices must weigh compliance costs, staffing requirements, and the impact on cash flow when evaluating a pharmacy conversion.

The decision also reshapes the strategic landscape for stakeholders. Employers and insurers are likely to lobby against legislative amendments that would extend pharmacy‑like protections to physicians, while dispensing practitioners may intensify advocacy efforts targeting the Florida Legislature. Meanwhile, regulatory counsel becomes essential to navigate anti‑kickback statutes and ownership rules should a practice consider pharmacy ownership. In the near term, providers should tighten documentation, anticipate higher denial rates, and monitor legislative activity to mitigate risk and preserve revenue streams.